Boer Deng

413 total citations · 1 hit paper
17 papers, 236 citations indexed

About

Boer Deng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Boer Deng has authored 17 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Boer Deng's work include Cancer, Lipids, and Metabolism (5 papers), Lipid metabolism and biosynthesis (3 papers) and Vitamin D Research Studies (2 papers). Boer Deng is often cited by papers focused on Cancer, Lipids, and Metabolism (5 papers), Lipid metabolism and biosynthesis (3 papers) and Vitamin D Research Studies (2 papers). Boer Deng collaborates with scholars based in China and United States. Boer Deng's co-authors include Chunxiao Zhou, Wei­min Kong, Chao Han, Ziyi Zhao, Victoria Bae‐Jump, Ziyi Zhao, Chao Han, Qiwei Liu, Wenchuan Sun and Fang Chen and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Pharmacology and Gynecologic Oncology.

In The Last Decade

Boer Deng

15 papers receiving 234 citations

Hit Papers

Biological role of matrix stiffness in tumor growth and t... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boer Deng China 7 68 67 65 52 43 17 236
Zhengfeng Wang China 9 89 1.3× 213 3.2× 77 1.2× 38 0.7× 82 1.9× 17 392
Deep Pokharel Australia 8 137 2.0× 277 4.1× 35 0.5× 44 0.8× 109 2.5× 9 385
Tongyao Yu China 8 42 0.6× 176 2.6× 20 0.3× 45 0.9× 86 2.0× 14 290
Jamie F. Lu Australia 7 144 2.1× 276 4.1× 27 0.4× 37 0.7× 136 3.2× 8 372
Carlos Saus Spain 10 71 1.0× 150 2.2× 26 0.4× 10 0.2× 32 0.7× 16 306
Amanda L. Bain Australia 12 93 1.4× 261 3.9× 47 0.7× 16 0.3× 43 1.0× 19 382
Fubo Zhou China 5 83 1.2× 148 2.2× 19 0.3× 41 0.8× 72 1.7× 6 323
Rahel Fitzel Germany 4 68 1.0× 141 2.1× 9 0.1× 51 1.0× 66 1.5× 7 302
Katarzyna J. Nytko Switzerland 9 44 0.6× 175 2.6× 33 0.5× 28 0.5× 161 3.7× 17 333
Yudan Xie China 8 41 0.6× 188 2.8× 31 0.5× 16 0.3× 102 2.4× 12 298

Countries citing papers authored by Boer Deng

Since Specialization
Citations

This map shows the geographic impact of Boer Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boer Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boer Deng more than expected).

Fields of papers citing papers by Boer Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boer Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boer Deng. The network helps show where Boer Deng may publish in the future.

Co-authorship network of co-authors of Boer Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Boer Deng. A scholar is included among the top collaborators of Boer Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boer Deng. Boer Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wang, Jiandong, Wei­min Kong, Catherine John, et al.. (2025). High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN/AKT/mTOR Pathway in Endometrial Cancer in vitro and in vivo. International Journal of Biological Sciences. 21(4). 1545–1565. 2 indexed citations
2.
Chen, Shuning, Weimin Kong, Nikita Sinha, et al.. (2025). Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer. Frontiers in Pharmacology. 16. 1520771–1520771.
3.
Zhao, Ziyi, Jiandong Wang, Wei­min Kong, et al.. (2024). Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer. Gynecologic Oncology. 186. 126–136. 1 indexed citations
4.
Kong, Weimin, Boer Deng, Catherine John, et al.. (2024). Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer. Gynecologic Oncology. 191. 116–123. 10 indexed citations
5.
Chen, Shuning, Weimin Kong, Boer Deng, et al.. (2024). Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cells. Journal of Cancer Research and Clinical Oncology. 150(8). 402–402.
6.
Deng, Boer, Wei­min Kong, Chao Han, et al.. (2024). The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications. Journal of Translational Medicine. 22(1). 290–290. 21 indexed citations
7.
Wang, Jiandong, Boer Deng, Shuning Chen, et al.. (2024). High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines. Gynecologic Oncology. 183. 93–102. 3 indexed citations
8.
Deng, Boer, et al.. (2024). Study of long-term effects of pelvic radiotherapy on the function of bone marrow in recurrent cervical cancer patients. International Journal of Medical Sciences. 21(10). 2000–2010. 2 indexed citations
9.
Deng, Boer, et al.. (2024). Review of the Potential Role of Ascorbate in the Prevention and Treatment of Gynecological Cancers. Antioxidants. 13(5). 617–617. 4 indexed citations
10.
Wang, Jiandong, Weimin Kong, Boer Deng, et al.. (2024). Palmitic Acid Exerts Anti-Tumorigenic Activities by Modulating Cellular Stress and Lipid Droplet Formation in Endometrial Cancer. Biomolecules. 14(5). 601–601. 6 indexed citations
11.
Xu, Guangxu, Ziyi Zhao, Weiya Z. Wysham, et al.. (2023). Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer. Frontiers in Oncology. 13. 1219923–1219923. 2 indexed citations
12.
Deng, Boer, Wei­min Kong, Ziyi Zhao, et al.. (2023). Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer. Cancers. 15(22). 5407–5407. 14 indexed citations
13.
Zhao, Ziyi, Xin Zhang, Yali Fan, et al.. (2023). Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo. International Journal of Oncology. 63(3). 3 indexed citations
14.
Fan, Yali, Ziyi Zhao, Xin Zhang, et al.. (2023). Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer. International Journal of Molecular Sciences. 24(15). 12375–12375. 10 indexed citations
15.
Zhao, Ziyi, Wenchuan Sun, Boer Deng, et al.. (2023). Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinoma. Annals of Medicine. 55(1). 603–614. 4 indexed citations
16.
Deng, Boer, et al.. (2022). Biological role of matrix stiffness in tumor growth and treatment. Journal of Translational Medicine. 20(1). 540–540. 136 indexed citations breakdown →
17.
Liu, Qiwei, et al.. (2021). Pregnancy outcomes of Chinese women undergoing IVF with embryonic cryopreservation as compared to natural conception. BMC Pregnancy and Childbirth. 21(1). 39–39. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026